A new treatment for prostate cancer is now available. Pluvicto is a targeted radioactive treatment for patients with metastatic prostate cancer. This treatment has been introduced at Piedmont Fayette Hospital.

Further details about Pluvicto and its application can be found through the hospital or related sources.

The introduction of Pluvicto provides an additional option for patients battling this specific type of cancer, but specifics about its use and availability are best obtained directly from the source.